Protective effect of B Vitamin on the prevention of Diabetic Retinopathy.
Phase 2
- Registration Number
- CTRI/2023/01/049218
- Lead Sponsor
- akshmi Kanta Mondal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Healthy human volunteers
Exclusion Criteria
1. Coronary artery diseases
2. Nepropathy
3. Hypertension
4. Histry of thrombotic event.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Mesurement of IL-32 <br/ ><br>2. Mesurement of MDPs like Humanin, MOTS-e. <br/ ><br>3.Mesurement of reactive aldehydes. <br/ ><br>4. Mesurement of lipid derived protective compound. <br/ ><br>5. Mesurement of Vitamin B.Timepoint: 12 hours.
- Secondary Outcome Measures
Name Time Method Vitamin B esetimation propely.Timepoint: 1 (12 hours)